Most recent

Advancing pediatric cancer research: Cure Group 4 meeting updates
On January 29, 2025, MBI researchers joined the latest Cure Group 4 Consortium meeting, connecting experts from the US, Canada, and Germany. The team discussed preparations for two upcoming FDA-approved clinical trials and set new research goals.

Accelerating progress: funding hope for childhood brain cancer
Brain tumors are the leading cause of cancer-related deaths in children, with medulloblastoma relapsing in 30% of cases. Current treatments, developed in the 1980s, often cause severe, lifelong side effects—when survival is even possible. Now, hope is

Race for Every Child: MBI makes its mark at a very special event
MBI’s first participation in the Race for Every Child, hosted in Washington, D.C., by our partner Children’s National Hospital, was simply sensational…